You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 2
  • CYP2B6 GENOTYPE BASED EFAVIRENZ DOSE RECOMMENDATIONS DURING RIFAMPICIN-BASED ANTITUBERCULOSIS CO-TREATMENT FOR A SUB-SAHARAN AFRICA POPULATION

Article metrics

Article menu

Download PDFPDF

XML
ABSTRACTS OF THE EIGHTH EDCTP FORUM, 6–9 NOVEMBER 2016
ABSTRACTS OF POSTER PRESENTATIONS
PA-069
CYP2B6 GENOTYPE BASED EFAVIRENZ DOSE RECOMMENDATIONS DURING RIFAMPICIN-BASED ANTITUBERCULOSIS CO-TREATMENT FOR A SUB-SAHARAN AFRICA POPULATION

 

Online download statistics by month:

Online download statistics by month: February 2017 to March 2024

AbstractFullPdf
Feb 20171509
Mar 2017700
Apr 2017902
May 20171307
Jun 20171003
Jul 20171503
Aug 20171404
Sep 2017702
Oct 2017903
Nov 20171303
Dec 2017801
Jan 20181200
Feb 20181304
Mar 20181604
Apr 20181803
May 20182202
Jun 20181400
Jul 2018801
Aug 20181001
Sep 20181202
Oct 20181201
Nov 20181201
Dec 20181003
Jan 2019800
Feb 20191404
Mar 2019804
Apr 2019203
May 2019904
Jun 20192003
Jul 20192606
Aug 20191303
Sep 2019202
Oct 2019502
Nov 20191104
Dec 20191404
Jan 2020602
Feb 20201805
Mar 2020402
Apr 2020201
May 20201405
Jun 20201202
Jul 20201803
Aug 2020203
Sep 20202001
Oct 2020602
Nov 20201606
Dec 20201802
Jan 202124016
Feb 20211002
Mar 2021603
May 20211103
Jun 2021003
Jul 2021004
Aug 2021003
Sep 2021005
Oct 20210014
Nov 202116016
Dec 20211607
Jan 20221005
Feb 2022801
Mar 2022404
Apr 2022802
May 20223204
Jun 20224206
Jul 20221600
Aug 20223406
Sep 20222608
Oct 20224605
Nov 20221205
Dec 20221801
Jan 202314010
Feb 2023800
Mar 2023600
Apr 2023408
May 20231306
Jul 2023405
Aug 2023405
Sep 2023601
Oct 2023201
Nov 20231200
Dec 20232802
Jan 2024808
Feb 20241603
Mar 20246036
Total10170340